Lanzamiento Enero 2027

Metaanálisis2009Financiado por la industria

Financiado en parte por California Walnut Commission

Effects of walnut consumption on blood lipids and other cardiovascular risk factors: a meta-analysis and systematic review

Banel DK, Hu FB

The American journal of clinical nutrition · 184 citas

Etiquetas de revisión

Financiado por la industria

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Metaanálisis (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento
Consumo medido con
No se indica

Quién lo pagó

Financiación
Financiado por la industria
Grupo de la industria
California Walnut Commission
Gobierno
National Institutes of Health
Gobierno
National Heart, Lung, and Blood Institute
Gobierno
NHLBI NIH HHS
Subvenciones
National Heart, Lung, and Blood Institute (HL60712); National Institutes of Health (HL 60712)

Según 4 financiadores declarados.

Publicación

Publicado
2009-05-21 · Am J Clin Nutr · vol. 90 · número 1 · págs. 56–63
Editorial
Elsevier BV
Citado
311 citas · más que el 88% de estudios similares · 2.3× el promedio de su campo
Referencias
32 trabajos
Acceso
Lectura gratuita
Áreas de investigación
Nuts composition and effects · Nutritional Studies and Diet · Fatty Acid Research and Health
Palabras clave
walnut consumption, serum lipids, LDL cholesterol, total cholesterol, HDL cholesterol, triglycerides, cardiovascular risk factors, polyunsaturated fatty acids, antioxidant capacity, inflammatory markers, body weight, body mass index
MeSH
humans, juglans, cardiovascular diseases, cholesterol, lipids, diet, risk factors, reference values, female, male, cholesterol, ldl

2 autores

  • Deirdre Banel🇺🇸 · autor de correspondenciaHarvard University
  • Frank B. Hu🇺🇸Harvard University

Resumen

El texto original del estudio, en el idioma en que se publicó.

Background

Consumption of nuts has been associated with a decreased risk of cardiovascular disease events and death. Walnuts in particular have a unique profile: they are rich in polyunsaturated fatty acids, which may improve blood lipids and other cardiovascular disease risk factors.

Objectives

We aimed to conduct a literature review and a meta-analysis to combine the results from several trials and to estimate the effect of walnuts on blood lipids.

Design

Literature databases were searched for published trials that compared a specifically walnut-enhanced diet with a control diet. We conducted a random-effects meta-analysis of weighted mean differences (WMDs) of lipid outcomes.

Results

Thirteen studies representing 365 participants were included in the analysis. Diets lasted 4-24 wk with walnuts providing 10-24% of total calories. When compared with control diets, diets supplemented with walnuts resulted in a significantly greater decrease in total cholesterol and in LDL-cholesterol concentrations (total cholesterol: WMD = -10.3 mg/dL, P < 0.001; LDL cholesterol: WMD = -9.2 mg/dL, P < 0.001). HDL cholesterol and triglycerides were not significantly affected by walnut diets more than with control diets (HDL cholesterol: WMD = -0.2, P = 0.8; triglycerides: WMD = -3.9, P = 0.3). Other results reported in the trials indicated that walnuts provided significant benefits for certain antioxidant capacity and inflammatory markers and had no adverse effects on body weight [body mass index (kg/m(2)): WMD = -0.4, P = 0.5; weight (kg): WMD = -0.05, P = 0.97].

Conclusions

Overall, high-walnut-enriched diets significantly decreased total and LDL cholesterol for the duration of the short-term trials. Larger and longer-term trials are needed to address the effects of walnut consumption on cardiovascular risk and body weight.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.